Jubilant Profits Spurred By Foreign Business
This article was originally published in PharmAsia News
Executive Summary
Buoyed chiefly by earnings from its foreign businesses, India's pharmaceuticals and chemicals major Jubilant Organosys reported a net profit of 4 billion rupees ($98 million) for the year ending March 31